1. Goldblum JR, Fletcher JA. Desmoid-type fibromatoses. In : Fletcher CD, Unni KK, Mertens F, editors. Pathology and genetics of tumors of soft tissue and bone. Lyon: IARC Press;2002. p. 83–84.
2. Enzinger FM, Weiss SW. Fibromatoses. In : Enzinger FM, Weiss SW, editors. Soft tissue tumors. 3rd ed. St Louis: Mosby;1995. p. 201–229.
3. Federle MP. Diagnostic imaging: abdomen. 1st ed. Salt Lake City: Amirsys;2004. p. 54–57.
4. Naylor EW, Gardner EJ, Richards RC. Desmoid tumors and mesenteric fibromatosis in Gardner's syndrome: report of kindred 109. Arch Surg. 1979; 114:1181–1185.
5. Simon NL, Mazur MT, Shingleton HM. Pelvic fibromatosis: an unusual gynecologic tumor. Obstet Gynecol. 1985; 65:767–769.
6. Brooks AP, Reznek RH, Nugent K, Farmer KC, Thomson JP, Phillips RK. CT appearances of desmoid tumours in familial adenomatous polyposis: further observations. Clin Radiol. 1994; 49:601–607.
7. Clark SK, Smith TG, Katz DE, Reznek RH, Phillips RK. Identification and progression of a desmoid precursor lesion in patients with familial adenomatous polyposis. Br J Surg. 1998; 85:970–973.
8. Einstein DM, Tagliabue JR, Desai RK. Abdominal desmoids: CT findings in 25 patients. AJR Am J Roentgenol. 1991; 157:275–279.
9. Chen YJ, Tam KW, Chen CS, Wu CH, Chen SC, Chan WP, et al. Case report: spontaneous isolated mesenteric fibromatosis presenting as megaduodenum. J Gastroenterol Hepatol. 1998; 13:383–386.
10. Messiou C, Chalmers AG, Dexter S. An unusual case of ureteric obstruction. Br J Radiol. 2005; 78:848–850.
11. Smith AJ, Lewis JJ, Merchant NB, Leung DH, Woodruff JM, Brennan MF. Surgical management of intra-abdominal desmoid tumours. Br J Surg. 2000; 87:608–613.
12. Baliski CR, Temple WJ, Arthur K, Schachar NS. Desmoid tumors: a novel approach for local control. J Surg Oncol. 2002; 80:96–99.
13. Hansmann A, Adolph C, Vogel T, Unger A, Moeslein G. High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors. Cancer. 2004; 100:612–620.
14. Klemi P, Alanen K, Hietanen S, Grenman S, Varpula M, Salmi T. Response of estrogen receptor-positive intraabdominal fibromatosis to aromatase inhibitor therapy. Obstet Gynecol. 2003; 102(5 Pt 2):1155–1158.